中国P站

Transfusion medicine; Infectious diseases; Blood safety; Historical review; Pathogen inactivation; Blood screening; Hepatitis; Future directions

Introduction

The field of transfusion medicine has evolved significantly since its early days, shaped by the ongoing challenge of infectious diseases. Blood transfusions are critical medical interventions that save countless lives, yet they have historically been associated with the risk of transmitting infectious agents. Early transfusion attempts, primarily through direct blood transfer, lacked the understanding of blood types and the presence of pathogens, leading to numerous complications and fatalities [1,2]. The introduction of blood typing in the early 20th century marked a pivotal advancement in transfusion safety, yet it was not until the emergence of HIV and hepatitis viruses in the latter half of the century that the field truly recognized the need for rigorous blood safety measures [2-6]. The lessons learned from these infectious disease outbreaks have led to the establishment of comprehensive screening protocols and testing methodologies designed to mitigate risks associated with blood transfusions. As we reflect on the evolution of transfusion medicine, it is essential to examine historical responses to infectious diseases and their implications for current practices. This review aims to synthesize the historical context of transfusion medicine concerning infectious diseases and explore future directions that may shape the safety and efficacy of blood transfusions.

Results and Discussion

Historical Milestones: The review identified key milestones in transfusion medicine, including the first successful blood transfusion in 1667, the discovery of blood types by Karl Landsteiner in 1901, and the implementation of routine screening for infectious agents in the 1980s. Impact of infectious diseases: The review highlighted the significant impact of infectious diseases on transfusion practices, particularly during the HIV/AIDS crisis of the 1980s, which led to increased awareness of blood safety and the establishment of the National Blood Policy in the United States [7]. Advancements in screening and testing: Technological advancements such as nucleic acid testing (NAT) and pathogen inactivation methods were identified as critical developments that enhanced the safety of blood transfusions. These technologies have reduced the window period for detecting infectious agents, thereby improving patient outcomes [8]. Current protocols and guidelines: The review summarized current blood safety protocols, including mandatory screening for hepatitis B and C viruses, HIV, and syphilis, and discussed the guidelines set forth by organizations such as the World Health Organization (WHO) and the American Association of Blood Banks (AABB).

Discussion

The findings of this review illustrate that the evolution of transfusion medicine has been profoundly influenced by the challenges posed by infectious diseases. Historical crises have driven significant advancements in blood safety measures, underscoring the importance of a proactive and responsive approach to emerging threats. Despite the progress made, the risk of transmitting infectious diseases through blood transfusions persists, particularly in the context of emerging pathogens and evolving public health challenges [9]. As globalization increases the movement of people and pathogens, the need for continuous vigilance and innovation in transfusion medicine becomes paramount. Future implications for transfusion medicine include the potential integration of advanced technologies, such as artificial intelligence and machine learning, to improve donor screening processes and predict transfusion-related complications [10]. Additionally, personalized medicine approaches may allow for more tailored transfusion strategies that consider individual patient characteristics, further enhancing safety and efficacy.

Conclusion

The evolution of transfusion medicine reflects a dynamic interplay between medical advances and the ongoing challenge of infectious diseases. Historical lessons learned from past infectious disease outbreaks have been instrumental in shaping current practices and ensuring the safety of blood transfusions. However, the field must remain vigilant and adaptable to emerging threats, embracing innovation and research to continually improve blood safety protocols. As we move forward, the integration of advanced technologies and personalized medicine approaches will be essential in addressing the complexities of transfusion medicine, ultimately enhancing patient outcomes and public health. The commitment to maintaining the highest standards of safety in blood transfusions is crucial for building trust and ensuring the continued efficacy of this lifesaving medical intervention.

Acknowledgement

None

Conflict of Interest

None

References

1. Osborne MP (2007). Lancet Oncol 8: 256-265.

   , ,

2. Fisher B (1977). World J Surg 1: 327-330.

   , ,

3. Heald RJ, Husband EM, Ryall RD (1982).Br J Surg 69: 613-616.

   , ,

4. Søndenaa K, Quirke P, Hohenberger W, Sugihara K, Kobayashi H, et al. ( 2014). Int J Colorectal Dis 29: 419-428.

   , ,

5. Dogan NU, Dogan S, Favero G, Köhler C, Dursun P, et al. (2019). J Oncol 3415630.

   , ,

6. Deijen CL, Vasmel JE, de Lange-de Klerk ESM, Cuesta MA, Coene PLO, et al. ( 2017). Surg Endosc. 31: 2607-2615.

   , ,

7. Vennix S, Pelzers L, Bouvy N, Beets GL, Pierie JP, et al. (2014). Cochrane Database Syst 005200.

   , ,

8. Nunobe S, Hiki N, Fukunaga T, Tokunaga M, Ohyama S, et al. (2008)World J Surg 32: 1466-1472.

   , ,

9. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, et al. (1980)Am J Med 69: 491-497.

   , ,

10. Correia MI, Waitzberg DL (2003)Clin Nutr 22: 235-239.

    , ,